Av Therapeutics Inc (AVTH) 0.0100 $AVTH AV Therapeutics

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Av Therapeutics Inc (AVTH) 0.0100 $AVTH

AV Therapeutics Successfully Completes GMP Synthesis of Its Lead Prostate Cancer Chemotherapeutic Drug, Capridine
GlobeNewswire - Mon Nov 24, 7:00AM CST
AV Therapeutics, Inc. ("AV Therapeutics" or the "Company" (OTCQB:AVTH), a developer of cancer therapeutics and vaccines, is pleased to announce the completion of GMP synthesis of its lead prostate cancer drug, Capridine.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Ford Experiences Sales Challenges Amid Economic Pressures

Updated Category News Views 255

Ford recently reported a dip in its new vehicle sales during Q3, with shares taking a hit of about 2% in early trading. This wasn’t just a Ford issue; it was an industry-wide problem. Major players like Toyota and General Motors were also waving red flags, citing similar challenges due to consumer hesitance tied to affordability. The crux? A fear that's keeping wallets...

Continue Reading
Monolithic Power Systems Shareholders Encouraged to Act Now

Updated Category News Views 179

Monolithic Power Systems Shareholders Encouraged to Act Now If you are a concerned shareholder of Monolithic Power Systems, Inc. (NASDAQ: MPWR), there's an important opportunity you need to know about. Recently, a class action lawsuit has been initiated regarding potential violations of federal securities laws by the company. This could significantly impact investors who...

Continue Reading
Aramis Group Shares Insights from 2025 Financial Report

Updated Category News Views 269

Aramis Group Shares Insights from 2025 Financial Report Aramis Group has recently announced the release of its half-year financial report for the year 2025, marking an important benchmark that highlights the company's performance in the used car market. The report covers activities up to March 31, 2025, demonstrating the continuous growth and strategic innovations that...

Continue Reading
CSX Reports Earnings Decline, Misses Revenue Expectations

Updated Category News Views 111

CSX's Fourth Quarter Earnings Report Overview CSX, a leading transportation company, recently released its financial results for the fourth quarter. The report highlighted a four earnings per share (EPS) of $0.38, which fell short of analysts' expectations by $0.06. This disappointing figure has drawn attention as it underscores the challenges the company currently faces....

Continue Reading
Innovative Handle Design Revolutionizes Vice Grip Functionality

Updated Category News Views 202

Introducing the Ireland Grip: A Game-Changer in Tool Design Inventors continually strive to enhance the tools we use in our everyday lives. Recently, one such inventor from Huntington conceived a brilliant idea to improve the ordinary vice grip. The result is the Ireland Grip, a revolutionary adjustment bolt handle that brings strength and simplicity to users everywhere....

Continue Reading